Trends in Cause of Death After Percutaneous Coronary Intervention

被引:167
作者
Spoon, Daniel B. [1 ]
Psaltis, Peter J. [1 ]
Singh, Mandeep [1 ]
Holmes, David R., Jr. [1 ]
Gersh, Bernard J. [1 ]
Rihal, Charanjit S. [1 ]
Lennon, Ryan J. [2 ]
Moussa, Issam D. [3 ]
Simari, Robert D. [1 ]
Gulati, Rajiv [1 ]
机构
[1] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA
[2] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA
[3] Mayo Clin, Div Cardiovasc Dis, Jacksonville, FL 32224 USA
关键词
cardiovascular diseases; coronary disease; death; percutaneous coronary intervention; ACUTE MYOCARDIAL-INFARCTION; GLYCOPROTEIN IIB/IIIA INHIBITOR; SUDDEN CARDIAC DEATH; BARE-METAL STENTS; MEDICAL THERAPY; ELUTING STENTS; FOLLOW-UP; METAANALYSIS; ANGIOPLASTY; STRATEGY;
D O I
10.1161/CIRCULATIONAHA.113.006518
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The impact of changing demographics on causes of long-term death after percutaneous coronary intervention (PCI) remains incompletely defined. Methods and Results We evaluated trends in cause-specific long-term mortality after index PCI performed at a single center from 1991 to 2008. Deaths were ascertained by scheduled prospective surveillance. Cause was determined via telephone interviews, medical records, autopsy reports, and death certificates. Competing-risks analysis of cause-specific mortality was performed using 3 time periods of PCI (1991-1996, 1997-2002, and 2003-2008). Final follow-up was December 31, 2012. A total of 19 077 patients survived index PCI hospitalization, of whom 6988 subsequently died (37%, 4.48 per 100 person-years). Cause was determined in 6857 (98.1%). Across 3 time periods, there was a 33% decline in cardiac deaths at 5 years after PCI (incidence: 9.8%, 7.4%, and 6.6%) but a 57% increase in noncardiac deaths (7.1%, 8.5%, and 11.2%). Only 36.8% of deaths in the recent era were cardiac. Similar trends were observed regardless of age, extent of coronary disease, or PCI indication. After adjustment for baseline variables, there was a 50% temporal decline in cardiac mortality but no change in noncardiac mortality. The decline in cardiac mortality was driven by fewer deaths from myocardial infarction/sudden death (P<0.001) but not heart failure (P=0.85). The increase in noncardiac mortality was primarily attributable to cancer and chronic diseases (P<0.001). Conclusions This study found a marked temporal switch from predominantly cardiac to predominantly noncardiac causes of death after PCI over 2 decades. The decline in cardiac mortality was independent of changes in baseline clinical characteristics. These findings have implications for patient care and clinical trial design.
引用
收藏
页码:1286 / 1294
页数:9
相关论文
共 37 条
[11]   5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial [J].
Fox, KAA ;
Poole-Wilson, P ;
Clayton, TC ;
Henderson, RA ;
Shaw, TRD ;
Wheatley, DJ ;
Knight, R ;
Pocock, SJ .
LANCET, 2005, 366 (9489) :914-920
[12]   Long-Term Outcome of a Routine Versus Selective Invasive Strategy in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome A Meta-Analysis of Individual Patient Data [J].
Fox, Keith A. A. ;
Clayton, Tim C. ;
Damman, Peter ;
Pocock, Stuart J. ;
de Winter, Robbert J. ;
Tijssen, Jan G. P. ;
Lagerqvist, Bo ;
Wallentin, Lars .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (22) :2435-2445
[13]   Heart Disease and Stroke Statistics-2013 Update A Report From the American Heart Association [J].
Go, Alan S. ;
Mozaffarian, Dariush ;
Roger, Veronique L. ;
Benjamin, Emelia J. ;
Berry, Jarett D. ;
Borden, William B. ;
Bravata, Dawn M. ;
Dai, Shifan ;
Ford, Earl S. ;
Fox, Caroline S. ;
Franco, Sheila ;
Fullerton, Heather J. ;
Gillespie, Cathleen ;
Hailpern, Susan M. ;
Heit, John A. ;
Howard, Virginia J. ;
Huffman, Mark D. ;
Kissela, Brett M. ;
Kittner, Steven J. ;
Lackland, Daniel T. ;
Lichtman, Judith H. ;
Lisabeth, Lynda D. ;
Magid, David ;
Marcus, Gregory M. ;
Marelli, Ariane ;
Matchar, David B. ;
McGuire, Darren K. ;
Mohler, Emile R. ;
Moy, Claudia S. ;
Mussolino, Michael E. ;
Nichol, Graham ;
Paynter, Nina P. ;
Schreiner, Pamela J. ;
Sorlie, Paul D. ;
Stein, Joel ;
Turan, Tanya N. ;
Virani, Salim S. ;
Wong, Nathan D. ;
Woo, Daniel ;
Turner, Melanie B. .
CIRCULATION, 2013, 127 (01) :E6-E245
[14]  
HENDERSON RA, 1989, LANCET, V2, P546
[15]   Death in Heart Failure A Community Perspective [J].
Henkel, Danielle M. ;
Redfield, Margaret A. ;
Weston, Susan A. ;
Gerber, Yariv ;
Roger, Veronique L. .
CIRCULATION-HEART FAILURE, 2008, 1 (02) :91-97
[16]   Cause of death analysis in the NHLBI PTCA registry: Results and considerations for evaluating long-term survival after coronary interventions [J].
Holmes, DR ;
Kip, KE ;
Kelsey, SF ;
Detre, KM ;
Rosen, AD .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (04) :881-887
[17]   Application of evidence-based medical therapy is associated with improved outcomes after percutaneous coronary intervention and is a valid quality indicator [J].
Jaber, WA ;
Lennon, RJ ;
Mathew, V ;
Holmes, DR ;
Lerman, A ;
Rihal, CS .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (08) :1473-1478
[18]   Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials [J].
Keeley, EC ;
Boura, JA ;
Grines, CL .
LANCET, 2003, 361 (9351) :13-20
[19]  
Kirtane AJ, 2012, NEW ENGL J MED, V367, P476, DOI [10.1056/NEJMoa1110717, 10.1056/NEJMc1206011]
[20]   5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome:: a follow-up study [J].
Lagerqvist, Bo ;
Husted, Steen ;
Kontny, Fredrik ;
Stahle, Elisabeth ;
Swahn, Eva ;
Wallentin, Lars .
LANCET, 2006, 368 (9540) :998-1004